2026 – State Expert Center of the Ministry of Health of Ukraine

Professional development Vacancies

2026

On amendments to the instructions for medical use of medicinal products containing angiotensin-converting enzyme inhibitors

05.10.2026 53

The State Expert Center of the Ministry of Health of Ukraine reminds holders of registration certificates of the need to check and, if necessary, make the relevant changes to…

Read more

On amendments to the instructions for medical use of medicinal products containing phenylephrine / tropicamide (phenylephrine / tropicamide)

30.09.2026 65

In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…

Read more

Changes to the safety information of medicinal products containing laronidase following the meeting of the Pharmacovigilance Risk Assessment Committee (PRAC) of 08 – 11 June 2026

21.09.2026 118

In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…

Read more

Regarding amendments to the instructions for medical use of medicinal products containing methotrexate

21.09.2026 97

In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…

Read more

Changes to the safety information of medicinal products containing ranibizumab following the meeting of the Pharmacovigilance Risk Assessment Committee (PRAC) of 08 – 11 June 2026

11.09.2026 105

In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…

Read more

Changes to the safety information of medicinal products containing acalabrutinib (acalabrutinib) following the meeting of the Pharmacovigilance Risk Assessment Committee (PRAC) of 08 – 11 June 2026

11.09.2026 97

In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…

Read more

Regarding amendments to the package inserts of medicinal products containing choline salicylate

08.09.2026 91

In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…

Read more

Changes to the safety information for medicinal products containing acetylsalicylic acid (acetylsalicylic acid) following the results of the meeting of the Coordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) held on 19 – 20 May 2026

08.09.2026 137

In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…

Read more

Regarding amendments to the instructions for medical use of medicinal products containing caffeine / dimenhydrinate (caffeine / dimenhydrinate), dimenhydrinate (dimenhydrinate)

08.09.2026 97

In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…

Read more

Regarding amendments to the package inserts of medicinal products containing carbidopa / levodopa and foscarbidopa / foslevodopa

01.09.2026 97

In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…

Read more